Previous Page  17 / 21 Next Page
Information
Show Menu
Previous Page 17 / 21 Next Page
Page Background

conferenceseries

.com

Volume 8

Journal of Alzheimers Disease & Parkinsonism

Dementia 2018

December 13-15, 2018

Page 40

Notes:

December 13-15, 2018 Abu Dhabi, UAE

13

th

Annual Conference on

Dementia and Alzheimer's Disease

In silico

Identification of novel ApoE4 inhibitor for Alzheimer’s disease therapy

Muhammad Asif Rasheed

COMSATS University Islamabad, Pakistan

A

poE4 is a major genetic risk factor due to its increase incidence of developing Alzheimer’s disease. The study was designed

to predict such compounds that may helpful in designing drug to suppress the over activity of apoE4 protein. 22 natural

compounds (marine, microorganism and plant derivative) were used as inhibitors and docked with apoE4 (PDB id 1B68).

6 Synthetic compounds (In clinical trials) were docked with target protein to compare and analyze the docking results with

natural compounds. Compounds S-Allyl-L-Cysteine, Epicatechin Gallate and Fulvic Acid show high binding affinity i.e. -7.1,

- 7 and -7 respectively. Epicatechin Gallate shows hydrogen bond with Gln156 and Asp35 and Fulvic Acid shows hydrogen

bonding with Glu27. In case of synthetic compounds Tideglusib did not show hydrogen bonding with any amino acid residue

of ApoE4 but show high binding affinity of -7.2 same as of natural compound S-Allyl-L-Cysteine which show high binding

affinity of -7.1 but did not show hydrogen bonding with any amino acid residue. Protein-Protein interactions of apoE4 show

physical and functional interaction with related proteins. Our study predict a compound Epicatechin Gallate on the basis

of binding affinity and hydrogen bonding with amino acid residue as a potential lead compound which may be used as an

inhibitor.

Biography

Muhammad Asif Rasheed has his expertise in bioinformatics approaches and passion in improving the health and wellbeing. He recently completed PhD studies

from Huazhong Agricultural University, Wuhan, China and applied different bioinformatics approaches to predict the virulence factors in

Mycoplasma bovis

bacteria.

Simultaneously he published review articles by applying different bioinformatics tools on proteins related to liver cirrhosis. Recently he is working on therapeutics

aspects of Alzheimer’s disease.

Muhammad Asif Rasheed, J Alzheimers Dis Parkinsonism 2018, Volume 8

DOI: 10.4172/2161-0460-C8-057